eScholarshipmetadata only
Health-related quality of life impact of idelalisib in patients with relapsed chronic lymphocytic leukemia (CLL): phase 3 results
1102 cardiorespiratory medicine and haematology (for), immunology (science-metrix), 3201 cardiovascular medicine and haematology (for-2020)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 675911
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.